维普中文期刊产品整合服务
223篇 您的检索式:作者名="Maluf"
    题名 作者 年代 出处 被引量
1Surveillance for Hepatocellular Carcinoma in Patients with Cirrhosis Improves Outcome显示文摘Richard Todd Stravitz Douglas M. Heuman Nisha Chand Richard K. Sterling Mitchell L. Shiffman Velimir A. Luketic Arun J. Sanyal Adil Habib Anastasios A. Mihas Ho-Chong S. Giles Daniel G. Maluf Adrian H. Cotterell Marc P. Posner Robert A. Fisher 2008The American Journal of Medicine2008,,2:3
2Advanced non-alcoholic steatohepatitis cirrhosis: A high-risk population for pre-liver transplant portal vein thrombosis显示文摘AIM To examine if liver transplant recipients with high-risk non-alcoholic steatohepatitis(NASH) are at increased risk for pre-transplant portal venous thrombosis.METHODS Data on all liver transplants in the United States from February 2002 through September 2014 were analyzed. Recipients were sorted into three distinct groups: High-risk(age > 60, body mass index > 30 kg/m2, hypertension and diabetes), low-risk and non-NASH cirrhosis. Multivariable logistic regression models were constructed.RESULTS Thirty-five thousand and seventy-two candidates underwent liver transplantation and of those organ recipients, 465 were transplanted for high-risk and 2775 for lowrisk NASH. Two thousand six hundred and twentysix(7.5%) recipients had pre-transplant portal vein thrombosis; 66(14.2%) of the high-risk NASH group had portal vein thrombosis vs 328(11.8%) of the lowrisk NASH group. In general, all NASH recipients were less likely to be male or African American and more likely to be obese. In adjusted multivariable regression analyses, high-risk recipients had the greatest risk ofpre-transplant portal vein thrombosis with OR = 2.11(95%CI: 1.60-2.76, P < 0.001) when referenced to the non-NASH group.CONCLUSION Liver transplant candidates with high-risk NASH are at the greatest risk for portal vein thrombosis development prior to transplantation. These candidates may benefit from interventions to decrease their likelihood of clot formation and resultant downstream hepatic decompensating events. Prospective study is needed.Jonathan G Stine Curtis K Argo Shawn J Pelletier Daniel G Maluf Stephen H Caldwell Patrick G Northup 2017World Journal of Hepatology2017,9,3:2
3La_(2-x)CexCu_(1-y)Zn_yO_4 perovskites for high temperature water-gas shift reaction显示文摘The performance of La2-xCexCu1-yZnyO4 perovskites as catalysts for the high temperature water-gas shift reaction (HT-WGSR) was investigated. The catalysts were characterized by EDS, XRD, BET surface area, TPR, and XANES. The results showed that all the perovskites exhibited the La2CuO4 orthorhombic structure, so the Pechini method is suitable for the preparation of pure perovskite. However, the La1.90Ce0.10CuO4 perovskite alone, when calcined at 350/700℃, also showed a (La0.935Ce0.065)2CuO4 perovskite with tetragonal structure, which produced a surface area higher than the other perovskites. The perovskites that exhibited the best catalytic performance were those calcined at 350/700 ℃ and, among these, La1.90Ce0.10CuO4 was outstanding, probably because of the high surface area associated with the presence of the (La0.935Ce0.065)2CuO4 perovskite with tetragonal structure and orthorhombic La2CuO4 phase.S. S. Maluf E. M. Assaf 2009Journal of Natural Gas Chemistry2009,18,2:2
4Genes involved in viral carcinogenesis and tumor initiation in hepatitis C virus-induced hepatocellular carcinoma显示文摘Mas VR Maluf DG Archer KJ 2009Mol Med2009,15,:1
5Aberrant promoter methylation can be useful as a marker of recurrent disease in patients with cervical intraepithelial neoplasia grade Ⅲ 显示文摘Terra AP Murta EF Maluf PJ 2007Tumori2007,93,:1
6Aberrant promoter methylation can be useful as a marker of recurrent disease in patients with cervical intraepithelial neoplasia grade IU 显示文摘TERRA AP MURTA EF MALUF PJ 2007Tumori2007,93,6:1
7Solid low-grade in situ carcinoma of the breast: Role of associated lesions and E-cadherin in differential diagnosis显示文摘Maluf HM Swanson PE Koerner FC 2001Am J Surg Pathol2001,25,2:1
8Nucleotides regulate the conformational state of the small terminase subunit from bacteriophage lambda:implications for the assembly of a viral genome-packaging motor显示文摘GAUSSIER H ORTEGA M E MALUF N K 2005Biochemistry2005,44,28:1
9Polymorphisms in cytokines and growth factor genes and their association with acute rejection and recurrence of hepatitis C virus disease in liver transplantation显示文摘Mas VR Fisher RA Maluf DG 2004Clin Genet2004,65,3:1
10Adult living donor versus decreased donor liver transplantation: a 6 - years single center experience 显示文摘Maluf DG Stravitz RT Cotterell AH 2005Am J Transplant2005,5,1:1
11Aberrant promoter methylation can be useful as a marker of recurrent disease in patients with cervical intraepithelial neoplasia grade Ⅲ显示文摘Terra AP Murta EF Maluf PJ 2007Tumori2007,93,:1
12Altered expression of the caffeine synthase gene in a naturally caffeine-free mutant of Coffea Arabica 显示文摘Maluf M P Silva C C Oliveira M 2009Genet Mol Biol2009,32,4:1
13Hepatic angiosarcoma and liver transplantation: case report and literature review显示文摘Maluf D Cotterell A Clark B 2005Transplant Proc2005,37,5:1
14Angiogenesis soluble factors as hepatocellular carcinoma noninvasive markers for monitoring hepatitis C virus cirrhotic patients awaiting liver transplantation 显示文摘Mas VR Maluf DG Archer KJ 2007Transplantation2007,84,10:1
15A Dimer of Escherichia coli UvrD is the active form of the helicase in vitro显示文摘Maluf NK Fischer CJ Lohman TM 2003J Mol Biol2003,325,5:1
16The promoter of a gene encoding an isoflavone reductase-like protein in coffee ( Coffea arabica ) drives a stress-responsive expression in leaves显示文摘Marcos Brandalise Fabio E. Severino Mirian P. Maluf Ivan G. Maia 2009Plant Cell Reports2009,,11:1
17Endometrial stromal sarcoma:objective response to letrozole显示文摘Maluf FC Sabbatini P Schwartz L 2001Gynecol Oncol2001,82,2:1
18Atypical cysts lobules: an early stage in the formation of low-grade ductal carcinoma in situ显示文摘Oyama T Maluf H Koerner F 1999Virchows Arch1999,435,4:1
19Ni catalysts with Mo promoter for methane steam reforming显示文摘Maluf S S Assaf E M 2009Fuel2009,88,:1
20Molecular pathways differentiate hepatitis C virus ( HCV ) recurrence from acute cellular rejection in HCV liver recipients显示文摘Gehrau R Maluf D Archer K 2011Mol Med2011,17,78:1
返回顶部 每页显示:
共12页 首页 上一页 第1页 下一页 末页 /12 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费